|
Remibrutinib Clinical Trials
1 actively recruiting trial across 1 location
Top Sponsors
- Washington University School of Medicine1
Indications
- Multiple Sclerosis (MS) - Relapsing-remitting1
- Multiple Sclerosis1
St Louis, Missouri1 trial
Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
Washington University School of Medicine in St. Louis
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.